Ramon Güimil García
Chief Tech/Sci/R&D Officer bij Hummingbird Diagnostics GmbH
Profiel
Ramon Güimil García is currently working as Vice President-Research & Development at Hummingbird Diagnostics GmbH.
Prior to this, he worked as Principal at The European Molecular Biology Laboratory and Nucleic Acid Synthesis Group.
Actieve functies van Ramon Güimil García
Bedrijven | Functie | Begin |
---|---|---|
Hummingbird Diagnostics GmbH
Hummingbird Diagnostics GmbH Medical SpecialtiesHealth Technology Hummingbird Diagnostics GmbH specializes in patient-friendly diagnostics for early disease detection, personalized medicine, and lifetime health monitoring. Hummingbird Diagnostics is based in Heidelberg, DE and was founded by Jochen Kohlhaas and Karoly Nikolich. The German company uses liquid biopsies based on miRNA biomarkers to detect diseases such as lung cancer, melanoma, breast cancer, multiple sclerosis, Alzheimer's, Parkinson's, heart diseases, and IBD. Jochen Kohlhaas has been the CEO since incorporation. | Chief Tech/Sci/R&D Officer | 30-11-2009 |
Eerdere bekende functies van Ramon Güimil García
Bedrijven | Functie | Einde |
---|---|---|
The European Molecular Biology Laboratory | Corporate Officer/Principal | - |
Nucleic Acid Synthesis Group | Corporate Officer/Principal | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
Hummingbird Diagnostics GmbH
Hummingbird Diagnostics GmbH Medical SpecialtiesHealth Technology Hummingbird Diagnostics GmbH specializes in patient-friendly diagnostics for early disease detection, personalized medicine, and lifetime health monitoring. Hummingbird Diagnostics is based in Heidelberg, DE and was founded by Jochen Kohlhaas and Karoly Nikolich. The German company uses liquid biopsies based on miRNA biomarkers to detect diseases such as lung cancer, melanoma, breast cancer, multiple sclerosis, Alzheimer's, Parkinson's, heart diseases, and IBD. Jochen Kohlhaas has been the CEO since incorporation. | Health Technology |
Nucleic Acid Synthesis Group |